Ohmi Y, Ohta A, Sasakura Y, Sato N, Yahata T, Santa K, Habu S, Nishimura T
Department of Immunology, Tokai University School of Medicine, Isehara, Japan.
Biochem Biophys Res Commun. 1997 Jun 27;235(3):461-4. doi: 10.1006/bbrc.1997.6733.
Treatment of lymphokine-activated killer (LAK) cells with phorbol ester (PMA) caused the downmodulation of LAK activity concomitantly with the inhibition of serine esterase (SE) release, which has been shown as a marker for perforin-dependent cell-mediated cytotoxicity. The reduction of perforin-dependent LAK activity by PMA-treatment appeared to be due to the disappearance of PMA-sensitive protein kinase C (PKC) isoforms such as PKC alpha, gamma, epsilon, theta. In contrast, Fas-mediated LAK activity was refractory against PMA-induced downregulation. Treatment of LAK cells with PMA caused a disappearance of cytotoxicity against Fas L5178Y tumor cells, while cytotoxicity against Fas+ transfectants was not affected by PMA treatment. Moreover, Fas-mediated LAK activity of perforin-knockout mice was not inhibited by PMA treatment. These results clearly demonstrated that Fas-mediated cytotoxicity could be dissociated from perforin-mediated cytotoxicity by their different requirement of PMA-sensitive PKC isoforms.
用佛波酯(PMA)处理淋巴因子激活的杀伤细胞(LAK细胞),会导致LAK活性下调,同时抑制丝氨酸酯酶(SE)释放,而丝氨酸酯酶已被证明是穿孔素依赖性细胞介导细胞毒性的标志物。PMA处理导致穿孔素依赖性LAK活性降低,似乎是由于PMA敏感的蛋白激酶C(PKC)亚型如PKCα、γ、ε、θ消失所致。相比之下,Fas介导的LAK活性对PMA诱导的下调具有抗性。用PMA处理LAK细胞会导致对Fas L5178Y肿瘤细胞的细胞毒性消失,而对Fas +转染细胞的细胞毒性不受PMA处理的影响。此外,PMA处理不会抑制穿孔素基因敲除小鼠的Fas介导的LAK活性。这些结果清楚地表明,Fas介导的细胞毒性与穿孔素介导的细胞毒性可因其对PMA敏感的PKC亚型的不同需求而分离。